Abstract

Cardiorespiratory fitness (CRF) is a strong, modifiable predictor of cardiovascular mortality in type 2 diabetes (T2D). Metformin is commonly prescribed for T2D management and is known to impair CRF adaptations to aerobic training, however its effect on CRF adaptations to high-intensity, high velocity resistance training (Power training; POWER) has never been studied.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call